Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-14
2006-03-14
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S208000, C546S276400, C548S125000, C548S126000, C548S127000, C514S361000
Reexamination Certificate
active
07012085
ABSTRACT:
The invention provides compounds of formula (I) wherein R0, R1, R2and A are as defined in the description, and the preparation thereof. The compounds of formula (I) have high affinity as α2adrenoceptors and hence are useful as pharmaceuticals.
REFERENCES:
patent: 5185364 (1993-02-01), Debernardis et al.
patent: 5407946 (1995-04-01), Lavielle et al.
patent: 296560 (1988-12-01), None
patent: WO 92 18475 (1992-10-01), None
patent: WO 92/22527 (1992-12-01), None
patent: WO 95/24391 (1995-09-01), None
patent: WO 00 03714 (2000-01-01), None
patent: WO 00/27815 (2000-05-01), None
(Chemical Abstracts, Abstract No. 3995b, A.V.El′tsov et al., “N-Aralkyl Derivatives of Phenylpyrrolidines”, vol. 34, No. 10, pp. 3344-3351 (1964) (XP 002164442).
Ahn, Kyo Han et al., Bioorg.Med.Chem.Lett., vol. 9, No. 10, pp. 1379-1384 (1999) (XP 004164896).
Nozulak Joachim
Seiler Max Peter
Borovian Joseph J.
Coppins Janet L.
Novartis AG
Saeed Kamal A.
Wilusz, Jr. E. Jay
LandOfFree
1,3 disubstituted pyrrolidines as α-2-adrenoceptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3 disubstituted pyrrolidines as α-2-adrenoceptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3 disubstituted pyrrolidines as α-2-adrenoceptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595628